Australian Clinical Labs to buy Healius for $1 billion

Australian Clinical Labs

19/03/2023 21:46

March 20 (Reuters) - Australian Clinical Labs  ACL.AX 
said on Monday it will acquire Healius  HLS.AX  by way of an off
market takeover in a A$1.52 billion ($1.02 billion) deal. 
    The pathology firm said it will offer 0.74 share for every 
one Healius share. 

 ($1 = 1.4896 Australian dollars)

 (Reporting by Navya Mittal in Bengaluru)
 ((Navya.Mittal@thomsonreuters.com;))